Cholera toxin B subunit activates arachidonic acid metabolism

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 794-799

  Peterson, Johnny W ^a   Finkelstein, Richard A ^b   Cantu, Juan ^a   Gessell, Deborah L ^a   Chopra, Ashok K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ARACHIDONIC ACID; CHOLERA TOXIN B SUBUNIT; CYCLIC AMP; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CHLORIDE TRANSPORT; CHOLERA; CONTROLLED STUDY; ENZYME ACTIVATION; LYMPHOMA CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; RABBIT; VIBRIO CHOLERAE;

EID: 0032912747     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.794-799.1999     Document Type: Article

References (47)

1. Anderson, G. D., S. D. Hauser, K. L. McGarity, M. E. Bremer, P. C. Isakson, and S. A. Gregory. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Investig. 97:2672-2679.
2. 2-mediated secretory response to 5-hydroxytryptamine in the small intestine of the rat in vivo. Gastroenterology 90:1972-1977.
3. 2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 96:368-376.
4. Boesman-Finkelstein, M., J. W. Peterson, L. S. Thai, and R. A. Finkelstein. 1996. A nontoxic cholera enterotoxin (CT) analog is chimeric with regard to both epitypes of CT-B subunits, CT-B-1 and CT-B-2. Infect. Immun. 64:346-348.
5. Bourne, H. R., P. Coffino, and G. M. Tomkins. 1975. Selection of a variant lymphoma cell deficient in adenylate cyclase. Science 187:750-752.
6. s and other GTP binding proteins. Proteins 6:222-230.
7. 2 synthesis in a murine macrophage cell line. J. Pharmacol. Exp. Ther. 244:765-773.
8. Chen, L. C., J. E. Rohde, and G. W. Sharp. 1971. Intestinal adenyl-cyclase activity in human cholera. Lancet i:939-941.
9. Chen, L. C., J. E. Rohde, and G. W. Sharp. 1972. Properties of adenyl cyclase from human jejunal mucosa during naturally acquired cholera and convalescence. J. Clin. Investig. 51:731-740.
10. Coffino, P., H. R. Bourne, and G. M. Tomkins. 1975. Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants. J. Cell. Physiol. 85: 603-610.
11. 2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. USA 87:2187-2191.
12. Field, M. 1971. Intestinal secretion: effect of cyclic AMP and its role in cholera. N. Engl. J. Med. 284:1137-1144.
13. Field, M., D. Fromm, Q. al-Awqati, and W. B. Greenough. 1972. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J. Clin. Investig. 51:796-804.
14. Finkelstein, R. A., and J. J. LoSpalluto. 1969. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid. J. Exp. Med. 130:185-202.
15. Fujita, T., M. Osaka, and Y. Yanatori. 1974. Granule release of enterochromaffin (EC) cells by cholera enterotoxin in the rabbit. Arch. Histol. Jpn. 36: 367-378.
16. Gots, R. E., S. B. Formal, and R. A. Giannella. 1974. Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion. J. Infect. Dis. 130:280-284.
17. Guerrant, R. L., G. D. Fang, N. M. Thielman, and M. C. Fonteles. 1994. Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin. Proc. Natl. Acad. Sci. USA 91:9655-9658.
18. Haga, T., E. M. Ross, H. J. Anderson, and A. G. Gilman. 1977. Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells. Proc. Natl. Acad. Sci. USA 74:2016-2020.
19. Häse, C. C., L. S. Thai, M. Boesman-Finkelstein, V. L. Mar, W. N. Burnette, H. R. Kaslow, L. A. Stevens, J. Moss, and R. A. Finkelstein. 1994. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs. Infect. Immun. 62:3051-3057.
20. 2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA 93:4885-4890.
21. Johnson, G. L., H. R. Kaslow, and H. R. Bourne. 1978. Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase. J. Biol. Chem. 253:7120-7123.
22. s and the olfactory-specific G-protein, Golf. J. Biol. Chem. 265:2671-2676.
23. Kaslow, H. R., V. E. Groppi, M. E. Abood, and H. R. Bourne. 1981. Cholera toxin can catalyze ADP-ribosylation of cytoskeletal proteins. J. Cell Biol. 91: 410-413.
24. Kimberg, D. V., M. Field, J. Johnson, A. Henderson, and E. Gershon. 1971. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J. Clin. Investing. 50:1218-1230.
25. Liang, Y., J. W. Peterson, C. A. Jackson, and J. C. Reitmeyer. 1990. Chloroquine inhibition of cholera toxin. FEBS Lett. 275:143-145.
26. Moss, J., and M. Vaughan. 1988. Cholera toxin and E. coli enterotoxins and their mechanisms of action, p. 39-87. In M. C. Hardegree and A. T. Tu (ed.), Handbook of natural toxins, vol. 4. Bacterial toxins. Marcel Dekker, Inc., New York, N.Y.
27. Nilsson, O., J. Cassuto, P. A. Larsson, M. Jodal, P. Lidberg, H. Ahlman, A. Dahlstrom, and O. Lundgren. 1983. 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats. Gut 24:542-548.
28. Peterson, J. W., W. D. Berg, and L. G. Ochoa. 1988. Indomethacin inhibits cholera toxin-induced cyclic AMP accumulation in Chinese hamster ovary cells. FEMS Microbiol. Lett. 49:187-192.
29. Peterson, J. W., J. Cantu, S. Duncan, and A. K. Chopra. 1993. Molecular mediators formed in the small intestine in response to cholera toxin. J. Diarrhoeal Dis. Res. 11:227-234.
30. Peterson, J. W., C. A. Jackson, and J. C. Reitmeyer. 1990. Synthesis of prostaglandins in cholera toxin-treated Chinese hamster ovary cells. Microb. Pathog. 9:345-353.
31. Peterson, J.W., Y. Lu, S. Duncan, J. Cantu, and A. K. Chopra. 1994. Interactions of intestinal mediators in the mode of action of cholera toxin. J. Med. Microbiol. 41:3-9.
32. Peterson, J. W., and L. G. Ochoa. 1989. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245:857-859.
33. 2-activating protein. Infect. Immun. 64:2137-2143.
34. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184:883-891.
35. Rabbani, G. H., and T. Butler. 1985. Indomethacin and chloroquine fail to inhibit fluid loss in cholera. Gastroenterology 89:1035-1037.
36. Rappaport, R. S., B. A. Rubin, and H. Tint. 1974. Development of a purified cholera toxoid. I. Purification of toxin. Infect. Immun. 9:294-303.
37. Reitmeyer, J. C., and J. W. Peterson. 1990. Stimulatory effects of cholera toxin on arachidonic acid metabolism in Chinese hamster ovary cells. Proc. Soc. Exp. Biol. Med. 193:181-184.
38. Schafer, D. E., W. D. Lust, B. Sircar, and N. D. Goldberg. 1970. Elevated concentration of adenosine 3′,5′-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin. Proc. Natl. Acad. Sci. USA 67:851-856.
39. Sharp, G. W. G., and S. Hynie. 1971. Stimulation of intestinal adenyl cyclase by cholera toxin. Nature 229:266-269.
40. Sjöqvist, A., J. Cassuto, M. Jodal, and O. Lundgren. 1992. Actions of serotonin antagonists on cholera toxin-induced intestinal fluid secretion. Acta Physiol. Scand. 145:229-237.
41. 2 concentrations in patients with acute cholera. Gut 26:188-193.
42. Thielman, N. M., M. Marcinkiewicz, J. Sarosiek, G. D. Fang, and R. L. Guerrant. 1997. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin. J. Clin. Investig. 99:1999-2004.
43. Uesaka, Y., Y. Otsuka, Z. Lin, S. Yamasaki, J. Yamaoka, H. Kurazono, and Y. Takeda. 1994. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb. Pathog. 16:71-76.
44. 2 in patients with acute cholera. Gut 33:643-645.
45. 2. J. Biol. Chem. 272:25693-25699.
46. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.
47. Yamamoto, S., Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee. 1997. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrhea-genicity but retain adjuvanticity. J. Exp. Med. 185:1203-1210.